With over 30 years of experience investing in the life sciences market, Aescap Genetics provide investors to invest in the future winners of this industry. An investment in the fund will not only allow for a good return on investment, but it also enables the development of better treatments for diseases with a high unmet medical need such as ALS, Alzheimer’s, Arthritis, Cancer, MS, Obesity, Parkinson’s etc.
The fund has a weekly liquidity with a 5-day notice period. The minimum investment amount for the Aescap Genetics fund is EUR 100.000,-. For wealth managers the minimum subscription amount is EUR 10.000,-.